Gina N Grantham - American Society of Clinical Oncology

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 32 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract CT267: Temsirolimus (T) in Patients (pts) with Solid Tumors with AKT1/3 Amplification (amp) or Mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Deepti Behl,Michael Rothe,Pam K. Mangat,Elizabeth Garrett-Mayer, Niklas Mackler,Herbert L. Duvivier,Philip J. Gold,Sapna R. Patel, Regan M. Duffy, Lauren A. Mauro,Eugene R. Ahn,Maria Bell,Carmen J. Calfa,Jean L. Grem,Jens Rueter,Margaret von Mehren,Gina N. Grantham,Abigail Gregory,Dominique C. Hinshaw,Susan Halabi,Richard L. Schilsky

Cancer Researchno. 7_Supplement (2024)

Cited0Views0Bibtex

Afatinib in Patients (pts) with Solid Tumors with Neuregulin 1 (NRG1) Fusions: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Jordi Rodon Ahnert,Michael Rothe,Pam K. Mangat,Elizabeth Garrett-Mayer,Timothy Lewis Cannon,Evthokia Hobbs,Gregory Peter Kalemkerian,Dominique C. Hinshaw, Abby Gregory,Gina N. Grantham,Susan Halabi,Richard L. Schilsky

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

Cited0Views0Bibtex

Abstract CT268: Palbociclib (P) in Patients (pts) with Solid Tumors with CCND1 Amplification (amp) or Mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Ramya Thota,Michael Rothe,Pam K. Mangat,Elizabeth Garrett-Mayer,Tareq Al Baghdadi,Evan Pisick,Olatunji B. Alese,Herbert L. Duvivier,Ajjai S. Alva, Apar Kishor Ganti, Raghava R. Induru,Apostolia M. Tsimberidou,Mehmet Akce,Navid Hafez,Evthokia Hobbs, Andrew Riddle,Margaret von Mehren,Gina N. Grantham,Abigail Gregory,Dominique C. Hinshaw,Susan Halabi,Richard L. Schilsky

Cancer Researchno. 7_Supplement (2024)

Cited0Views0Bibtex

Temsirolimus (T) in Patients (pts) with Solid Tumors with AKT1/3 Amplification (amp) or Mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

CANCER RESEARCHno. 7 (2024)

Cited0Views0Bibtex

Nivolumab Plus Ipilimumab (N+I) in Patients (pts) with Solid Tumors with High Tumor Mutational Burden (HTMB): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

John K. Chan,Michael Rothe,Pam K. Mangat, Elizabeth Garrett-Mayer,Timothy Lewis Cannon, Eugene R. Ahn,Paul Swiecicki, Evthokia Hobbs,Reza Nazemzadeh,Maria C. Bell,Peter Joel Hosein,Funda Meric-Bernstam,Dominique C. Hinshaw, Abby Gregory,Gina N. Grantham,Susan Halabi,Richard L. Schilsky

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn